CVS Health Corp. buy The Goldman Sachs Group, Inc.
Summary
This prediction ended on 03.05.25 with a price of €59.37. The BUY prediction by The_Goldman_Sachs_Gr finished with a performance of 16.55%. The_Goldman_Sachs_Gr has a follow-up prediction for CVS Health Corp. where he still thinks CVS Health Corp. is a Buy. Dividends of €1.86 are taken into consideration when calculating the performance. The_Goldman_Sachs_Gr has 50% into this predictionCVS Health (symbol CVS) is a health care company that operates a retail pharmacy chain and offers health care services. The company is headquartered in Rhode Island, USA and has more than 9,900 locations. CVS Health operates three business segments: Pharmacy Services, Retail/LTC and Health Care Benefits. The Pharmacy Services segment offers pharmacy benefit management solutions and includes CVS Caremark, which serves more than 94 million plan members. The Retail/LTC segment operates CVS Pharmacy, the largest pharmacy chain in the United States, and provides long-term care pharmacy services through Omnicare. The Health Care Benefits segment offers a range of health insurance products and services through Aetna, which was acquired by CVS Health in 2018.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| CVS Health Corp. | 2.041% | 2.041% | 59.320% |
| iShares Core DAX® | 0.323% | 2.208% | 21.610% |
| iShares Nasdaq 100 | 0.145% | -0.987% | 5.603% |
| iShares Nikkei 225® | 0.091% | -1.421% | 12.897% |
| iShares S&P 500 | 0.371% | -0.469% | 3.470% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread CVS Health Corp. diskutieren
In the thread Trading CVS Health Corp.